The Characteristics and Prognosis of Diffuse-Type Early Gastric Cancer Diagnosed during Health Check-Ups
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Background/Aims: Because of the poor prognosis of diffuse-type gastric cancer, early detection is important. We investigated the clinical characteristics and prognosis of diffuse-type early gastric cancer (EGC) diagnosed in subjects during health check-ups. Methods: Among 121,111 subjects who underwent gastroscopy during a routine health check-up, we identified 282 patients with 286 EGC lesions and reviewed their clinical and tumor-specific parameters. Results: Patients with diffuse-type EGC were younger, and 48.1% of them were female. Serum anti-Helicobacter pylori IgG (Hp-IgG) was positive in 90.7% of diffuse-type EGC patients (vs 75.9% of intestinal-type EGC, p=0.002), and the proportion of diffuse-type EGC cases increased significantly with increasing Hp-IgG serum titers (p<0.001). Diffuse-type EGC had pale discolorations on the tumor surface (26.4% vs 4.0% in intestinal-type EGC, p<0.001) and were often located in the middle third of the stomach. Submucosal invasion or regional nodal metastasis was observed more commonly in patients with diffuse-type EGC. However, during the median follow-up period of 50 months, 5-year disease-free survival rates did not differ between the groups. Conclusions: Diffuse-type EGC shows different clinical and endoscopic characteristics. Diffuse-type EGC is more closely associated with Hp-IgG seropositivity and a higher serum titer. Early detection results in excellent prognosis.
Abstract
Background/Aims: Because of the poor prognosis of diffuse-type gastric cancer, early detection is important. We investigated the clinical characteristics and prognosis of diffuse-type early gastric cancer (EGC) diagnosed in subjects during health check-ups. Methods: Among 121,111 subjects who underwent gastroscopy during a routine health check-up, we identified 282 patients with 286 EGC lesions and reviewed their clinical and tumor-specific parameters. Results: Patients with diffuse-type EGC were younger, and 48.1% of them were female. Serum anti-Helicobacter pylori IgG (Hp-IgG) was positive in 90.7% of diffuse-type EGC patients (vs 75.9% of intestinal-type EGC, p=0.002), and the proportion of diffuse-type EGC cases increased significantly with increasing Hp-IgG serum titers (p<0.001). Diffuse-type EGC had pale discolorations on the tumor surface (26.4% vs 4.0% in intestinal-type EGC, p<0.001) and were often located in the middle third of the stomach. Submucosal invasion or regional nodal metastasis was observed more commonly in patients with diffuse-type EGC. However, during the median follow-up period of 50 months, 5-year disease-free survival rates did not differ between the groups. Conclusions: Diffuse-type EGC shows different clinical and endoscopic characteristics. Diffuse-type EGC is more closely associated with Hp-IgG seropositivity and a higher serum titer. Early detection results in excellent prognosis.
참고문헌 (34)
- Lee HJ, "Gastric cancer in Korea", Gastric Cancer, 5, pp.177~182 (2002)
- "National cancer control programs in Korea", J Korean Med Sci, 22(Suppl), pp.S3~S4 (2007)
- Il Ju Choi, "Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups", Clinical Endoscopy, 47(6), pp.497~503 (2014), 대한소화기내시경학회
- Lauren P, "The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification", Acta Pathol Microbiol Scand, 64, pp.31~49 (1965)
- Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process: first American Cancer Society award lecture on cancer epidemiology and prevention", Cancer Res, 52, pp.6735~6740 (1992)
- Nardone G, "Review article: Helicobacter pylori and molecular events in precancerous gastric lesions", Aliment Pharmacol Ther, 20, pp.261~270 (2004)
- Watanabe M, "Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis", Int J Cancer, 131, pp.2632~2642 (2012)
- Ribeiro MM, "Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma", Cancer, 47, pp.780~784 (1981)
- Adachi Y, "Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type", Cancer, 89, pp.1418~1424 (2000)
- Lee T, "Clinical impact of the extent of lymph node micrometastasis in undifferentiated-type early gastric cancer", Oncology, 86, pp.244~252 (2014)
- Japanese Gastric Cancer Association, "Japanese classification of gastric carcinoma: 2nd English edition", Gastric Cancer, 1, pp.10~24 (1998)
- Participants in the Paris Workshop, "The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002", Gastrointest Endosc, 58(6 Suppl), pp.S3~S43 (2003)
- Kimura K, "An endoscopic recognition of the atrophic border and its significance in chronic gastritis", Endoscopy, 1, pp.87~97 (1969)
- Travis WD, "World Health Organization classification of tumors" (2000), IARC
- Soetikno R, "Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract", J Clin Oncol, 23, pp.4490~4498 (2005)
- Gotoda T, "Endoscopic resection of early gastric cancer", Gastric Cancer, 10, pp.1~11 (2007)
- Na HK, "Atrophic and metaplastic progression in the background mucosa of patients with gastric adenoma", PLoS One, 12, pp.e0169456~ (2017)
- Kang HY, "Progression of atrophic gastritis and intestinal metaplasia drives Helicobacter pylori out of the gastric mucosa", Dig Dis Sci, 51, pp.2310~2315 (2006)
- Kwak HW, "Characteristics of gastric cancer according to Helicobacter pylori infection status", J Gastroenterol Hepatol, 29, pp.1671~1677 (2014)
- Tatemichi M, "Japan Public Health Center Study Group. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen", Acta Oncol, 47, pp.360~365 (2008)
- Yoshida T, "Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer", Int J Cancer, 134, pp.1445~1457 (2014)
- Tatemichi M, "JPHC Study Group. Clinical significance of IgG antibody titer against Helicobacter pylori", Helicobacter, 14, pp.231~236 (2009)
- Kreuning J, "Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects", J Clin Pathol, 47, pp.227~231 (1994)
- Hsu PI, "Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia", J Clin Gastroenterol, 25, pp.587~591 (1997)
- Kishikawa H, "Helicobacter pylori antibody titer and gastric cancer screening", Dis Markers, 2015, pp.156719~ (2015)
- Ninomiya Y, "Unrecognizable intramucosal spread of diffuse-type mucosal gastric carcinomas of less than 20 mm in size", Endoscopy, 32, pp.604~608 (2000)
- Sawada S, "Expansion of indications for endoscopic treatment of undifferentiated mucosal gastric cancer: analysis of intramucosal spread in resected specimens", Dig Dis Sci, 55, pp.1376~1380 (2010)
- Adachi Y, "Microvascular architecture of early gastric carcinoma: microvascular-histopathologic correlates", Cancer, 72, pp.32~36 (1993)
- Choi JM, "Endoscopic predictors for undifferentiated histology in differentiated gastric neoplasms prior to endoscopic resection", Surg Endosc, 30, pp.89~98 (2016)
- 박미성, "Clinicopathologic Characteristics of Interval Gastric Cancer in Korea", Gut and Liver, 9(2), pp.167~173 (2015), 거트앤리버 발행위원회
- Chon HJ, "Differential prognostic implications of gastric signet ring cell carcinoma: stage adjusted analysis from a single high-volume center in Asia", Ann Surg, 265, pp.946~953 (2017)
- Pyo JH, "Clinicopathological features and prognosis of mixed-type T1a gastric cancer based on Lauren’s classification", Ann Surg Oncol, 23(Suppl 5), pp.784~791 (2016)
- Khanderia E, "The influence of gastric cancer screening on the stage at diagnosis and survival: a meta-analysis of comparative studies in the far east", J Clin Gastroenterol, 50, pp.190~197 (2016)
- Gong EJ, "Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study", J Gastroenterol Hepatol, 29, pp.301~309 (2014)